Tobacco

background

Nicotiana tabacum is the most commonly used tobacco plant for commercial tobacco products. The leaves of the tobacco plant are the source of all smoking and chewing tobacco products. Tobacco leaves contain around 2-8% nicotine.
Tobacco has been reportedly used for many conditions in traditional and folk medicine. Limited research suggests that tobacco may be used to treat Alzheimer's disease, schizophrenia, or nicotine cravings.
However, it is well-known that smoking tobacco represents a major public health concern. Nicotine is highly addictive and contains several compounds known to cause cancer. Nearly one-third of people who try a cigarette later become addicted to nicotine. An estimated 25-35% of all cancer-related deaths are due to nicotine.

Related Terms

2,3,6-Trimethyl-1,4-naphthoquinone, 2-methylquinone, 2-naphthylamine, acrolein, albumen, aldehydes, anabasine, anatabine, anatalline, anethole, anthalin, areca nut, arghile, aromatic hydrocarbons, beta-naphthylamine, benzo[a]pyrene, betel quid, bidi, carbon monoxide, catechols, cembrene, chewing tobacco, choline, cigar, cigarette, collidine, fatty acids, furfurol, goza, gum, harman, hookah, hubble bubble, hydrocyanic acid, ketones, latakria, narghile, narkeela, nicotelline, Nicotiana fruticosa, Nicotiana latissima, Nicotiana multivulvis, Nicotiana persica, Nicotiana quadrivalis, Nicotiana repandu, Nicotiana rustica, nicotianin, nicotine, nicotinine, nitric oxide, nitrosamines, norharman, organic acids, orinoco, paraffins, paraphenols, Persian tobacco, phenolic compounds, phenols, pipe, polycyclic aromatic hydrocarbons (PAH), propionic acid, pyrene, pyridine, resin, shisha, smokeless tobacco, snuff, tabacine, tabacinine, tannins, toombak (Sudan), Turkish tobacco, water pipe, waxes.
Note: This summary does not review quitting smoking in detail. Information on quitting smoking may be accessed under a separate Natural Standard summary. Also, this summary does not review nicotine-only supplements in detail. Products containing only nicotine are not considered dietary supplements.

evidence table

These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
 
Alzheimer's disease (Grade: C)
Although this area has not been well studied in humans, limited research suggests that nicotine may promote memory recovery and protect against Alzheimer's disease. However, conclusive evidence in this area is currently lacking. More high-quality research is needed before any firm suggestions may be made, especially on the use of the
Schizophrenia (Grade: C)
Although this has not been well studied in humans, tobacco has been suggested as a risk factor for schizophrenia. Compared to healthy people, those with schizophrenia are more likely to smoke, according to some evidence. However, it has also been suggested that nicotine aids in the relief of psychotic symptoms. Conclusive evidence in this area is currently lacking. More high-quality research is needed, especially on the use of the
Smoking cessation (Grade: C)
Limited research suggests that various nicotine products may reduce cravings to smoke and help people quit smoking. Such products include nicotine chewing gums, lozenges, and the patch. More high-quality research in this area is needed, especially on the use of the
Stress (Grade: D)
According to early research findings, evidence is lacking to support the claim that either the nicotine content of cigarettes or the act of smoking itself helps reduce stress. More high-quality research in this area is needed, especially on the use of the
Sexual arousal (dysfunction) (Grade: F)
Some research suggests that smoking and nicotine use may be associated with adverse sexual function in both males and females. Cases of impotence and decreased sexual arousal have been seen. More high-quality research in this area is needed, especially on the use of the